Fabimycin
Fabimycin is a FabI inhibitor with potent antibacterial activity against gram-negative bacteria. Fabimycin is effective against drug-resistant gram-negative Infections in vivo[1].
Product Specifications
CAS Number
2651965-71-6
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/fabimycin.html
Solubility
10 mM in DMSO
Smiles
O=C(/C=C/C(C=C1CC[C@@H]2[NH3+])=CN=C1NC2=O)N(C)CC(O3)=C(C)C4=C3C=CC=C4.[Cl-]
Molecular Formula
C23H25ClN4O3
Molecular Weight
440.92
References & Citations
[1]Erica N. Parker, et al. An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections. DOI: 10.1021/acscentsci.2c00598.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Methyl ({4-[ (morpholin-4-yl) methyl]phenyl}methyl) amine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
VLB48281-01 50 mg
Methyl ({4-[ (morpholin-4-yl) methyl]phenyl}methyl) amine
Sign In for Pricing
View Details VLB48281-02 0.5 g
Methyl ({4-[ (morpholin-4-yl) methyl]phenyl}methyl) amine
Sign In for Pricing
View Details orb2571187 200 µL
Fruit fly CG12942 Rabbit Polyclonal Antibody (FITC)
Sign In for Pricing
View Details 
K1001703 1.0 µg DNA
HSPD1P12 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 